Todd Bazemore - 07 Mar 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)

Role: Interim Chief Executive Officer, President and Chief Operating Officer
Signature: /s/ Mary Reumuth, Attorney-in-Fact
Issuer symbol: KALA
Transactions as of: 07 Mar 2025
Transactions value $: $0
Form type: 4
Filing time: 10 Mar 2025, 20:00:08 UTC
Previous filing: 07 Jan 2025
Next filing: 04 Jun 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KALA	Stock Option (right to buy)	Award	$0	+45.2K		$0.00	45.2K	07 Mar 2025	Common Stock	45.2K	$7.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on March 7, 2025 and vests as to 1/12th of the shares underlying the option at the end of each successive one-month period over a one-year period following February 11, 2025, subject to the Reporting Person's continued employment with the Issuer.

Remarks:

Interim Chief Executive Officer, President and Chief Operating Officer